v3.26.1
Stockholders’ Deficiency (Details Narrative) - USD ($)
 3 Months Ended 13 Months Ended
Apr. 01, 2025
Mar. 31, 2025
Mar. 31, 2024
May 11, 2026
Dec. 31, 2025
Dec. 31, 2024
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Accrued dividend payable   $ 359,453       $ 7,205
Stock based compensation expense   104,475 $ 288,895      
General and administrative expense   67,200        
Research and development expense   33,400        
Accrued compensation   34 2,597      
Unrecognized stock-based compensation expense   $ 5,864        
Weighted average remaining period   3 months        
Consulting Services [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Accrued compensation     262,351      
Accrued compensation     1,831      
Stockholder's deficiency   $ 100,600 260,520      
Equity Option [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Stock options granted, shares   4,525,000        
Stock options granted, value   $ 100,600        
Warrant Amendment Agreements [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Stock based compensation expense   $ 17,200        
Investor [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Warrants to purchase common stock   200,000        
Exercise price   $ 0.75        
Fair value of warrants   $ 11,860        
Investor [Member] | Subsequent Event [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Warrants term       5 years 5 years  
Warrants to purchase common stock       20,000    
Exercise price       $ 0.75    
Series B Convertible Preferred Stock [Member] | Investor [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Proceeds from issuance of convertible preferred stock   $ 25,000        
Shares issued   3,333        
Warrants term   5 years        
Warrants to purchase common stock   37,500        
Exercise price   $ 0.75        
Fair value of warrants   $ 3,006        
Series B Convertible Preferred Stock [Member] | Investor [Member] | Subsequent Event [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Proceeds from issuance of convertible preferred stock $ 310,000          
Shares issued       3,333    
Preferred Stock [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Accrued additional preferred dividends   352,248 $ 326,665      
Accrued dividend payable   359,453       $ 7,205
Preferred Stock [Member] | Series B Convertible Preferred Stock [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Shares issued     3,333      
Common Stock [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Accrued compensation   $ 3,909 $ 29,141      
Common Stock [Member] | Subsequent Event [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Shares issued       428,572    
Common Stock [Member] | Investor [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Shares issued   428,572        
Warrants term   10 years        
Warrants to purchase common stock   428,572        
Exercise price   $ 0.35        
Fair value of warrants   $ 57,803        
Proceeds from issuance of Common Stock   150,000        
Common Stock [Member] | Investor [Member] | Subsequent Event [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Proceeds from issuance of Common Stock $ 100,000          
Warrant [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Accrued compensation   $ 3,875 $ 26,544      
Warrant [Member] | Advisory Agreement [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Warrants term   5 years        
Warrants to purchase common stock   150,000        
Exercise price   $ 0.75        
Fair value of warrants   $ 9,773        
Warrant vesting percentage   20.00%        
Warrant [Member] | Warrant Amendment Agreements [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Warrants term   4 years        
Warrants to purchase common stock   353,323        
Exercise price   $ 0.75        
Warrant [Member] | Subsequent Event [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Warrants to purchase common stock       25,000    
Exercise price       $ 0.75    
Warrant [Member] | Subsequent Event [Member] | Advisory Agreement [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Warrants term       5 years    
Warrants to purchase common stock       120,000    
Exercise price       $ 0.75    
Warrant vesting percentage       33.00%    
Warrant [Member] | Investor [Member] | Subsequent Event [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Warrants term       5 years    
Stock Options [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Vested term   5 years        
Exercise price   $ 0.75